Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.
Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.
A phase 3 randomized trial found that Moderna’s next-generation COVID-19 vaccine, mRNA-1283, was non-inferior to the earlier mRNA-1273 vaccine in preventing COVID-19 and produced stronger neutralizing antibody responses.
Researchers report significant improvements in breath odor and oral health after four weeks using a natural essential oil rinse in patients with obesity and periodontitis.
Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.
Researchers urge physicians to reconsider diphenhydramine use due to safety concerns, high sedation risk, and safer second-generation antihistamine alternatives.